{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:56:36Z","timestamp":1791093396066,"version":"4.1.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1212\/wnl.48.2.358","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:26:38Z","timestamp":1336915598000},"page":"358-362","source":"Crossref","is-referenced-by-count":301,"title":["Long-term effects of tetrabenazine in hyperkinetic movement disorders"],"prefix":"10.1212","volume":"48","author":[{"given":"Joseph","family":"Jankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199502000-00001"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"4","year":"1962","unstructured":"Pletscher A, Brossi A, Gey KF. Benzoquinolizine derivatives: a new class of monoamine-decreasing drugs with psychotropic action. Int Rev Neurobiol 1962;4:275-306.","journal-title":"Int Rev Neurobiol"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"1","year":"1975","unstructured":"Carlsson A. Monoamine-depleting drugs. Pharmacol Ther 1975;1:394-400.","journal-title":"Pharmacol Ther"},{"key":"e_1_3_1_5_2","first-page":"1","volume":"19","year":"1976","unstructured":"Lane JD, Smith JE, Shea PA, McBride WJ. Neurochemical changes following the administration of depleters of biogenic monoamine. Life Sci 1976;19:1663-1667.","journal-title":"Life Sci"},{"key":"e_1_3_1_6_2","first-page":"3","volume":"201","year":"1977","unstructured":"Kuczenski R. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools. J Pharmacol Exp Ther 1977;201:357-367.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_7_2","first-page":"7","volume":"27","year":"1988","unstructured":"Pearson SJ, Reynolds GP. Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease. Neuropharmacology 1988;27:717-719.","journal-title":"Neuropharmacology"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"12","year":"1982","unstructured":"Login IS, Cronin MJ, MacLeod RM. Tetrabenazine has properties of a dopamine receptor antagonist. Ann Neurol 1982;12:257-262.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_9_2","first-page":"5","volume":"225","year":"1983","unstructured":"Reches A, Burke RE, Kuhn CM, et al. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in the rat brain. J Pharmacol Exp Ther 1983;225:515-521.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170103"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"60","year":"1993","unstructured":"Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using tetrabenazine and positron emission tomography. J Neurochem 1993;60:2315-2318.","journal-title":"J Neurochem"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"7","year":"1983","unstructured":"Fahn S. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents. Adv Neurol 1983;7:276-279.","journal-title":"Adv Neurol"},{"key":"e_1_3_1_13_2","first-page":"2","volume":"37","year":"1983","unstructured":"Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Adv Neurol 1983;37:227-289.","journal-title":"Adv Neurol"},{"key":"e_1_3_1_14_2","first-page":"3","volume":"38","year":"1988","unstructured":"Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988;38:391-394.","journal-title":"Neurology"},{"key":"e_1_3_1_15_2","first-page":"4","volume":"11","year":"1982","unstructured":"Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982;11:41-47.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.35.1.1"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.1.1"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674378803300101"},{"key":"e_1_3_1_19_2","first-page":"6","volume":"181","year":"1993","unstructured":"Kalian M, Lerner V, Goldman M. Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine. J Nerv Ment Dis 1993;181:649-651.","journal-title":"J Nerv Ment Dis"},{"key":"e_1_3_1_20_2","first-page":"9","volume":"43","year":"1993","unstructured":"Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology 1993;43:937-941.","journal-title":"Neurology"},{"key":"e_1_3_1_21_2","first-page":"4","volume":"1304","year":"1973","unstructured":"Kazamatsuri H, Chein C-P, Cole J. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine. Am J Psychiatry 1973;1304:479-483.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198205010-00002"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.1.1"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870010101"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870040101"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870070506"},{"key":"e_1_3_1_27_2","first-page":"3","volume":"31","year":"1974","unstructured":"Pakkenberg H, Fog R. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both. Arch Neurol 1974;31:352-353.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432875"},{"key":"e_1_3_1_29_2","first-page":"2","volume":"46","year":"1970","unstructured":"Fog R, Pakkenberg H. Combined Nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Acta Neurol Scand 1970;46:249-251.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_30_2","first-page":"1","volume":"1","year":"1974","unstructured":"McLellan DL, Chalmers RJ, Johnson RH. A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea. Lancet 1974;1:104-107.","journal-title":"Lancet"},{"key":"e_1_3_1_31_2","first-page":"5","volume":"1","year":"1976","unstructured":"Huang CY, McLeod JG, Holland RT, Elliot C. Tetrabenazine in the treatment of Huntington's chorea. Med J Aust 1976;1:583-584.","journal-title":"Med J Aust"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6052.1"},{"key":"e_1_3_1_33_2","first-page":"8","volume":"39","year":"1978","unstructured":"Toglia JU, McGlamery M, Sambandham RR. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders. J Clin Psychiatry 1978;39:81-87.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_34_2","first-page":"3","volume":"13","year":"1979","unstructured":"Godwin-Austen RB. The treatment of the choreas and athetotic dystonias. J R Coll Physicians Lond 1979;13:35-38.","journal-title":"J R Coll Physicians Lond"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230705"},{"key":"e_1_3_1_36_2","first-page":"2","volume":"4","year":"1989","unstructured":"Gimenez-Roldan S, Mateo D. Huntington's disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements. Neurologia 1989;4:282-287.","journal-title":"Neurologia"},{"key":"e_1_3_1_37_2","first-page":"8","volume":"31","year":"1974","unstructured":"Sweet RD, Brun R, Shapiro E, Shapiro AK. Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry 1974;31:857-861.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_38_2","first-page":"6","volume":"34","year":"1984","unstructured":"Jankovic J, Glaze DG, Frost JD. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 1984;34:688-692.","journal-title":"Neurology"},{"key":"e_1_3_1_39_2","first-page":"1","volume":"16","year":"1974","unstructured":"Heggarty H, Wright T. Tetrabenazine in athetoid cerebral palsy. Dev Med Child Neurol 1974;16:137-142.","journal-title":"Dev Med Child Neurol"},{"key":"e_1_3_1_40_2","first-page":"1","volume":"219","year":"1972","unstructured":"Pearce J. Reversal of hemiballismus by tetrabenazine. JAMA 1972;219:1345.","journal-title":"JAMA"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198503000-00001"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520370010002"},{"key":"e_1_3_1_43_2","first-page":"1","volume":"43","year":"1986","unstructured":"Jankovic J, Pardo R. Segmental myoclonus: clinical and pharmacologic study. Arch Neurol 1986;43:1025-1031.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_44_2","first-page":"2","volume":"42","year":"1975","unstructured":"Furukawa T, Ushizima I, Ono N. Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine. Psychopharmacologia 1975;42:243-248.","journal-title":"Psychopharmacologia"},{"key":"e_1_3_1_45_2","first-page":"1","volume":"33","year":"1983","unstructured":"Reches A, Hassan MN, Jackson VR, Fahn S. Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine. Life Sci 1983;33:157-160.","journal-title":"Life Sci"},{"key":"e_1_3_1_46_2","first-page":"3","volume":"11","year":"1991","unstructured":"Chou JCY. Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991;11:3-21.","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1983.tb01510.x"},{"key":"e_1_3_1_48_2","first-page":"4","volume":"37","year":"1969","unstructured":"Calne DB, Webster RA. Tremor induced by tetrabenazine. Br J Pharmacol 1969;37:468-475.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_1_49_2","first-page":"6","volume":"15","year":"1992","unstructured":"Mateo D, Munoz-Blanco JL, Gimenez-Roldan S. Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. Clin Neuropharmacol 1992;15:63-68.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1996.11.s1.6"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.1.1"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060103"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.2.358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:04:08Z","timestamp":1711533848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.2.358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1212\/WNL.48.2.358"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.2.358","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}